TCT-432 FANTOM II trial: Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold – 24-Month Follow-up Clinical Outcomes Final Results

Authors :: Louise Gambone
D Dudek
Alexandra J. Lansky
Jeffrey S. Anderson
Joachim Weber-Albers
Alexandre Abizaid
Didier Carrié
Georgios Bouras
Matthias Lutz
Source :: Journal of the American College of Cardiology. 72:B174
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Scaffold
medicine.medical_specialty
business.industry
Sirolimus
medicine
Fantom
Cardiology and Cardiovascular Medicine
business
computer
medicine.drug
Month follow up
computer.programming_language
Surgery

Full Text Access

Tools